Diagnostic performance of standard breast MRI compared to dedicated axillary MRI for assessment of node-negative and node-positive breast cancer

被引:12
|
作者
Samiei, Sanaz [1 ,2 ,3 ]
Smidt, Marjolein L. [1 ,3 ]
Vanwetswinkel, Sigrid [2 ]
Engelen, Sanne M. E. [1 ]
Schipper, Robert-Jan [1 ,4 ]
Lobbes, Marc B. I. [2 ,3 ,5 ]
van Nijnatten, Thiemo J. A. [2 ,3 ]
机构
[1] Maastricht Univ, Med Ctr, Dept Surg, POB 5800, NL-6202 AZ Maastricht, Netherlands
[2] Maastricht Univ, Med Ctr, Dept Radiol & Nucl Med, Maastricht, Netherlands
[3] Maastricht Univ, GROW Sch Oncol & Dev Biol, Maastricht, Netherlands
[4] Catharina Hosp, Dept Surg, Eindhoven, Netherlands
[5] Zuyderland Med Ctr, Dept Med Imaging, Sittard Geleen, Netherlands
关键词
Breast cancer; Axilla; Lymph node; Metastasis; Magnetic resonance imaging; DIFFUSION-WEIGHTED MRI; LYMPH-NODE; PREOPERATIVE ASSESSMENT; ACCURACY; METASTASIS; CONTRAST; SENTINEL; RADIOTHERAPY; COEFFICIENT; MAMMOGRAPHY;
D O I
10.1007/s00330-020-06760-6
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Objectives To investigate whether breast MRI has comparable diagnostic performance as dedicated axillary MRI regarding assessment of node-negative and node-positive breast cancer. Methods Forty-seven patients were included. All had undergone both breast MRI and dedicated axillary MRI, followed by surgery. All included breast MRI exams had complete field of view (FOV) of the axillary region. First, unenhanced T2-weighted (T2W) and subsequent diffusion-weighted (DW) images of both MRI exams were independently analyzed by two breast radiologists using a confidence scale and compared to histopathology. ADC values were measured by two researchers independently. Diagnostic performance parameters were calculated on a patient-by-patient basis. Results T2W breast MRI had the following diagnostic performance: sensitivity of 50.0% and 62.5%, specificity of 92.3%, PPV of 57.1% and 62.5%, NPV of 90.0% and 92.3%, and AUC of 0.72 for reader 1 and 0.78 for reader 2. T2W dedicated axillary MRI had the following diagnostic performance: sensitivity of 37.5% and 62.5%, specificity of 82.1% and 92.3%, PPV of 44.6% and 50.0%, NPV of 87.8% and 91.4%, and AUC of 0.65 for reader 1 and 0.73 for reader 2. In both evaluations, addition of DW images resulted in comparable diagnostic performance. For both breast MRI and dedicated axillary MRI, there was no significant difference between mean ADC values of benign and malignant lymph nodes. Conclusions T2W breast MRI with complete FOV of the axillary region has comparable diagnostic performance as T2W dedicated axillary MRI regarding assessment of node-negative and node-positive breast cancer. Optimization of T2W breast MRI protocol by including a complete FOV of the axillary region can, therefore, be recommended in clinical practice.
引用
收藏
页码:4212 / 4222
页数:11
相关论文
共 50 条
  • [31] Shc proteins are strong, independent prognostic markers for both node-negative and node-positive primary breast cancer
    Davol, PA
    Bagdasaryan, R
    Elfenbein, GJ
    Maizel, AL
    Frackelton, AR
    CANCER RESEARCH, 2003, 63 (20) : 6772 - 6783
  • [32] Axillary lymph node response to neoadjuvant systemic therapy with dedicated axillary hybrid 18F-FDG PET/MRI in clinically node-positive breast cancer patients: a pilot study
    de Mooij, C. M.
    Samiei, S.
    Mitea, C.
    Lobbes, M. B. I.
    Kooreman, L. F. S.
    Heuts, E. M.
    Beets-Tan, R. G. H.
    van Nijnatten, T. J. A.
    Smidt, M. L.
    CLINICAL RADIOLOGY, 2022, 77 (10) : E732 - E740
  • [33] Avoidance of axillary lymph node dissection in selected patients with node-positive breast cancer
    Noguchi, M.
    EJSO, 2008, 34 (02): : 129 - 134
  • [34] EVALUATION OF AXILLARY LYMPH NODE STATUS IN BREAST CANCER WITH MRI
    Goro Yoshimura Takeo Sakurai Syoji Oura Takaomi Suzuma Takeshi Tamaki Qifeng YangDepartment of Surgery Kihoku Hospital Wakayama Medical College Katsuragi Itogun Wakayama Japan
    中国现代普通外科进展, 1999, (03) : 38 - 44
  • [35] Evaluation of axillary lymph node status in breast cancer with MRI
    Yoshimura G.
    Sakurai T.
    Oura S.
    Suzuma T.
    Tamaki T.
    Umemura T.
    Kokawa Y.
    Yang Q.
    Breast Cancer, 1999, 6 (3) : 249 - 258
  • [36] Real-World Outcomes of Adjuvant Chemotherapy for Node-Negative and Node-Positive HER2-Positive Breast Cancer
    Veitch, Zachary
    Khan, Omar F.
    Tilley, Derek
    Ribnikar, Domek
    Kostaras, Xanthoula
    King, Karen
    Tang, Patricia
    Lupichuk, Sasha
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2019, 17 (01): : 47 - 56
  • [37] Stratification of axillary lymph node metastasis risk with breast MRI in breast cancer
    Chen, Jieying
    Su, Xiaolian
    Xu, Tingting
    Luo, Qifeng
    Zhang, Lin
    Tang, Guangyu
    FUTURE ONCOLOGY, 2022, 18 (15) : 1849 - 1859
  • [38] Is Axillary Dissection Still Useful in Node-negative Early Breast Cancer?
    Petrelli, F.
    Cabiddu, M.
    Ghilardi, M.
    Borgonovo, K.
    Barni, S.
    EUROPEAN JOURNAL OF CANCER, 2012, 48 : S201 - S201
  • [39] Axillary recurrence in sentinel lymph node-negative breast cancer patients
    Poletti, P.
    Fenaroli, P.
    Milesi, A.
    Paludetti, A.
    Mangiarotti, S.
    Virotta, G.
    Candiago, E.
    Bettini, A.
    Caremoli, E. R.
    Labianca, R.
    Tondini, C.
    ANNALS OF ONCOLOGY, 2008, 19 (11) : 1842 - 1846
  • [40] Breast MRI radiomics for the pretreatment prediction of response to neoadjuvant chemotherapy in node-positive breast cancer patients
    Drukker, Karen
    Edwards, Alexandra
    Doyle, Christopher
    Papaioannou, John
    Kulkarni, Kirti
    Giger, Maryellen L.
    JOURNAL OF MEDICAL IMAGING, 2019, 6 (03)